FDA And EMA Revising GMP Rules To Address Supply Chain Deficiencies
FDA and the European Medicines Agency are establishing new GMP requirements for manufacturers to identify and control the supply chains for their drug products
FDA and the European Medicines Agency are establishing new GMP requirements for manufacturers to identify and control the supply chains for their drug products